1.
Amadori S. New agents for the treatment of acute myeloid leukemia: gemtuzumab ozogamicin. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2024 Nov. 22];2(5). Available from: https://www.pagepress.org/journals/hmr/article/view/733